Cholecystokinin Inhibits Inducible Nitric Oxide Synthase Expression by Lipopolysaccharide-Stimulated Peritoneal Macrophages

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Saia, Rafael Simone ^a   Mestriner, Fabíola Leslie ^a   Bertozi, Giuliana ^a   Cunha, Fernando Queiróz ^a   Cárnio, Evelin Capellari ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; SYNAPTOTAGMIN I; ANTIINFLAMMATORY AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ADULT; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONCENTRATION CAMP; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; NONHUMAN; OXIDATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHOLECYSTOKININ; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84925996764     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/896029     Document Type: Article

References (48)

1. K. Miyake, "Innate recognition of lipopolysaccharide by tolllike receptor 4-MD-2", Trends in Microbiology, vol. 12, no. 4, pp. 186-192, 2004.
2. S. L. Doyle and L. A. J. O'Neill, "Toll-like receptors: from the discovery of NFκB to new insights into transcriptional regulations in innate immunity", Biochemical Pharmacology, vol. 72, no. 9, pp. 1102-1113, 2006.
3. L. Ulloa and K. J. Tracey, "The "cytokine profile": a code for sepsis", Trends in Molecular Medicine, vol. 11, no. 2, pp. 56-63, 2005.
4. F. A. Bozza, J. I. Salluh, A. M. Japiassu et al., "Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis", Critical Care, vol. 11, no. 2, article R49, 2007.
5. J. Cavaillon and M. Adib-Conquy, "Monocytes/macrophages and sepsis", Critical Care Medicine, vol. 33, no. 12, supplement, pp. S506-S509, 2005.
6. S. S. Santos, M. K. Brunialti, O. Rigato, F. R. Machado, E. Silva, and R. Salomao, "Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes", Shock, vol. 38, no. 1, pp. 18-23, 2012.
7. P. Pacher, J. S. Beckman, and L. Liaudet, "Nitric oxide and peroxynitrite in health and disease", Physiological Reviews, vol. 87, no. 1, pp. 315-424, 2007.
8. S. Daff, "NO synthase: structures and mechanisms", Nitric Oxide-Biology and Chemistry, vol. 23, no. 1, pp. 1-11, 2010.
9. R. S. Saia, J. A. Anselmo-Franci, and E. C. Carnio, "Hypothermia during endotoxemic shock in female mice lacking inducible nitric oxide synthase", Shock, vol. 29, no. 1, pp. 119-126, 2008.
10. A. Pautz, J. Art, S. Hahn, S. Nowag, C. Voss, and H. Kleinert, "Regulation of the expression of inducible nitric oxide synthase", Nitric Oxide-Biology and Chemistry, vol. 23, no. 2, pp. 75-93, 2010.
11. Y. M. Kim, B. S. Lee, K. Y. Yi, and S. G. Paik, "Upstream NFkappa B site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages", Biochemical and Biophysical Research Communications, vol. 236, no. 3, pp. 655-660, 1997.
12. Q.-W. Xie, Y. Kashiwabara, and C. Nathan, "Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase", The Journal of Biological Chemistry, vol. 269, no. 7, pp. 4705-4708, 1994.
13. M. Dufresne, C. Seva, and D. Fourmy, "Cholecystokinin and gastrin receptors", Physiological Reviews, vol. 86, no. 3, pp. 805-847, 2006.
14. R. Chandra and R. A. Liddle, "Cholecystokinin", Current Opinion in Endocrinology, Diabetes and Obesity, vol. 14, no. 1, pp. 63-67, 2007.
15. X. Zhao, Y. Ling, Y. Li, A. Meng, and H. Xing, "Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats", World Journal of Gastroenterology, vol. 11, no. 22, pp. 3405-3410, 2005.
16. S. Miyamoto, K. Shikata, K. Miyasaka et al., "Cholecystokinin plays a novel protective role in diabetic kidney through antiinflammatory actions onmacrophage: anti-inflammatory effect of cholecystokinin", Diabetes, vol. 61, no. 4, pp. 897-907, 2012.
17. F. M. Zuelli, E. C. Carnio, and R. S. Saia, "Cholecystokinin protects rats against sepsis induced by Staphylococcus aureus", Medical Microbiology and Immunology, vol. 203, no. 3, pp. 165-176, 2014.
18. R. S. Saia, G. Bertozi, F. L. Mestriner, J. Antunes-Rodrigues, F. Queiróz Cunha, and E. C. Cárnio, "Cardiovascular and inflammatory response to cholecystokinin during endotoxemic shock", Shock, vol. 39, no. 1, pp. 104-112, 2013.
19. P. Sacerdote, C. J. Wiedermann, L. M. Wahl, C. B. Pert, and M. R. Ruff, "Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen", Peptides, vol. 12, no. 1, pp. 167-176, 1991.
20. P. Cuq, A. Gross, A. Terraza et al., "mRNA's encoding CCKB but not CCKA receptors are expressed in human T lymphocytes and Jurkat lymphoblastoid cells", Life Sciences, vol. 61, no. 5, pp. 543-555, 1997.
21. S. J. Xu, W. J. Gao, B. Cong, Y. X. Yao, and Z. Y. Gu, "Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages", Acta Pharmacologica Sinica, vol. 25, no. 10, pp. 1347-1353, 2004.
22. M. de La Fuente, M. Campos, M. Del Rio, and A. Hernanz, "Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide", Regulatory Peptides, vol. 55, no. 1, pp. 47-56, 1995.
23. M. Carrasco, M. del Rio, A. Hernanz, and M. de La Fuente, "Inhibition of human neutrophil functions by sulfated and nonsulfated cholecystokinin octapeptides", Peptides, vol. 18, no. 3, pp. 415-422, 1997.
24. S. Li, Z. Ni, B. Cong et al., "CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappa B pathway", Shock, vol. 27, pp. 678-686, 2007.
25. B. Cong, S. J. Li, Y. X. Yao, G. J. Zhu, and Y. L. Ling, "Effect of cholecystokinin octapeptide on tumor necrosis factor alpha transcription and nuclear factor-kappa B activity induced by lipopolysaccharide in rat pulmonary interstitial macrophages", World Journal of Gastroenterology, vol. 8, no. 4, pp. 718-723, 2002.
26. World Medical Association and American Physiological Society, "Guiding principles for research involving animals and human beings", The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 283, no. 2, pp. R281-R283, 2002.
27. Guide for the Care and Use of Laboratory Animals, The National Academies Press, 8th edition, 2011.
28. M. W. Pfaffl, "Anew mathematical model for relative quantification in real-time RT-PCR.", Nucleic Acids Research, vol. 29, no. 9, article e45, 2001.
29. M. Marshall, J. Keeble, and P. K. Moore, "Effect of a nitric oxide releasing derivative of paracetamol in a rat model of endotoxaemia", British Journal of Pharmacology, vol. 149, no. 5, pp. 516-522, 2006.
30. J. Bultinck, P. Sips, L. Vakaet, P. Brouckaert, and A. Cauwels, "Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock", FASEB Journal, vol. 20, no. 13, pp. 2363-2365, 2006.
31. S. Hashimoto, K. Morohoshi, T. Suzuki, and K. Matsushima, "Lipopolysaccharide-inducible gene expression profile in human monocytes", Scandinavian Journal of Infectious Diseases, vol. 35, no. 9, pp. 619-627, 2003.
32. T. Lubbers, J. de Haan, M. Hadfoune et al., "Lipid-enriched enteral nutrition controls the inflammatory response inmurine Gram-negative sepsis", Critical Care Medicine, vol. 38, no. 10, pp. 1996-2002, 2010.
33. Y. L. Ling, A. H. Meng, X. Y. Zhao, B. E. Shan, J. L. Zhang, and X. P. Zhang, "Effect of cholecystokinin on cytokines during endotoxic shock in rats", World Journal of Gastroenterology, vol. 7, no. 5, pp. 667-671, 2001.
34. S. Li, B. Cong, Y. Yan, Y. Yao, C. Ma, and Y. Ling, "Cholecystokinin octapeptide inhibits the in vitro expression of CD14 in rat pulmonary interstitial macrophages induced by lipopolysaccharide", Chinese Medical Journal, vol. 115, no. 2, pp. 276-279, 2002.
35. A. H. Meng, Y. L. Ling, X. P. Zhang, and J. L. Zhang, "Antiinflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat", World Journal of Gastroenterology, vol. 8, no. 4, pp. 712-717, 2002.
36. F. Arnalich, E. Garcia-Palomero, J. López et al., "Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis", Infection and Immunity, vol. 68, no. 4, pp. 1942-1945, 2000.
37. H. Bohrer, F. Qiu, T. Zimmermann et al., "Role of NFkappaB in themortality of sepsis", The Journal of Clinical Investigation, vol. 100, no. 5, pp. 972-985, 1997.
38. G. Bernardin, A. D. Strosberg, A. Bernard, M. Mattei, and S. Marullo, "Beta-adrenergic receptor-dependent and - independent stimulation of adenylate cyclase is impaired during severe sepsis in humans", Intensive Care Medicine, vol. 24, no. 12, pp. 1315-1322, 1998.
39. P. K. Risoe, Y. Wang, J. F. Stuestøl, A. O. Aasen, J. E. Wang, and M. K. Dahle, "Lipopolysaccharide attenuates mRNA levels of several adenylyl cyclase isoforms in vivo", Biochimica et Biophysica Acta, vol. 1772, no. 1, pp. 32-39, 2007.
40. Y. Osawa, H. T. Lee, C. A. Hirshman, D. Xu, and C. W. Emala, "Lipopolysaccharide-induced sensitization of adenylyl cyclase activity in murine macrophages", American Journal of Physiology: Cell Physiology, vol. 290, no. 1, pp. C143-C151, 2006.
41. F. Okada, S. Nagao, Y. Harada et al., "The role of cyclic AMP in the lipopolysaccharide-induced suppression of thymidine kinase activity in macrophage", Biochimica et Biophysica Acta, vol. 1265, no. 2-3, pp. 201-208, 1995.
42. D. Ma, P. Wu, R. W. Egan, M. M. Billah, and P. Wang, "Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes", Molecular Pharmacology, vol. 55, no. 1, pp. 50-57, 1999.
43. L. Pang and J. R. Hoult, "Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages", Biochemical Pharmacology, vol. 53, no. 4, pp. 493-500, 1997.
44. B. Zhang, I. Nweze, J. Lakshmanan, and B. G. Harbrecht, "Activation of a cyclic amp-guanine exchange factor in hepatocytes decreases nitric oxide synthase expression", Shock, vol. 39, no. 1, pp. 70-76, 2013.
45. E. A. Wall, J. R. Zavzavadjian, M. S. Chang et al., "Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105", Science Signaling, vol. 2, no. 75, article ra28, 2009.
46. B. F. Roettger, R. U. Rentsch, D. Pinon et al., "Dual pathways of internalization of the cholecystokinin receptor", Journal of Cell Biology, vol. 128, no. 6, pp. 1029-1041, 1995.
47. B. Ohlsson, K. Borg, H. Mulder, J. F. Rehfeld, J. Axelson, and F. Sundler, "Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-a receptor in the rat pancreas", Scandinavian Journal of Gastroenterology, vol. 35, no. 6, pp. 612-618, 2000.
48. B. Ohlsson, K. Borg, J. F. Rehfeld, J. Axelson, and F. Sundler, "The method of administration of cholecystokinin determines the effects evoked in the pancreas", Pancreas, vol. 23, no. 1, pp. 94-101, 2001.